Staar Promotes Visian ICL For Myopia As Cataract Sales Decline
This article was originally published in The Gray Sheet
Executive Summary
A successful rollout of Staar Surgical's recently FDA-approved Visian implantable contact lens (ICL) nearly offset steadily declining sales of its cataract products during the first quarter
You may also be interested in...
People In Brief
KCI, Applied Biosystems shuffle: Catherine Burzik becomes CEO of San Antonio-based Kinetic Concepts Nov. 6, succeeding chief executive Denny Ware, who intends to retire at the end of 2006. For the past three years, Burzik led Applied Biosystems, a unit of Applera, as president. She held senior positions at Johnson & Johnson, for a time as president of its Ortho-Clinical Diagnostics business, and Eastman Kodak. Burzik plans to focus on R&D initiatives and expansion of KCI's footprint in international markets. In the wake of Burzik's exit, Tony White, chairman of Applera, will act as interim president of Applied Biosystems until a permanent successor is named...
People In Brief
KCI, Applied Biosystems shuffle: Catherine Burzik becomes CEO of San Antonio-based Kinetic Concepts Nov. 6, succeeding chief executive Denny Ware, who intends to retire at the end of 2006. For the past three years, Burzik led Applied Biosystems, a unit of Applera, as president. She held senior positions at Johnson & Johnson, for a time as president of its Ortho-Clinical Diagnostics business, and Eastman Kodak. Burzik plans to focus on R&D initiatives and expansion of KCI's footprint in international markets. In the wake of Burzik's exit, Tony White, chairman of Applera, will act as interim president of Applied Biosystems until a permanent successor is named...
FDA Issues Resolved, Staar Shoots For Stronger Sales Of Cataract Products
Staar Surgical is committed to restoring domestic cataract product sales in 2006 after putting its regulatory woes to rest during the fourth quarter